Literature DB >> 22151039

Management of intrathecal catheter-tip inflammatory masses: an updated 2007 consensus statement from an expert panel.

Timothy Deer1, Elliot S Krames, Samuel Hassenbusch, Allen Burton, David Caraway, Stuart Dupen, James Eisenach, Michael Erdek, Eric Grigsby, Phillip Kim, Robert Levy, Gladstone McDowell, Nagy Mekhail, Sunil Panchal, Joshua Prager, Richard Rauck, Michael Saulino, Todd Sitzman, Peter Staats, Michael Stanton-Hicks, Lisa Stearns, K Dean Willis, William Witt, Kenneth Follett, Mark Huntoon, Leong Liem, James Rathmell, Mark Wallace, Eric Buchser, Michael Cousins, Ann Ver Donck.   

Abstract

Background.  Expert panel of physicians and nonphysicians, all expert in intrathecal (IT) therapies, convened in the years 2000 and 2003 to make recommendations for the rational use of IT analgesics based on the preclinical and clinical literature known up to those times, presentations of the expert panel, discussions on current practice and standards, and the result of surveys of physicians using IT agents. An expert panel of physicians and convened in 2007 to review previous recommendations and to form recommendations for the rational use of IT agents as they pertain to new scientific and clinical information regarding the etiology, prevention and treatment for IT granuloma. Method.  A review of preclinical and clinical literature from 2000 to 2006 was undertaken and disseminated to an expert panel of physicians. Focused discussions concerning the rational use of IT agents and its relationship to the etiology of, prevention of, and treatment of IT granuloma were held. Results.  This report presents here new knowledge of the etiology of catheter tip granuloma and guidelines for its prevention and treatment.
© 2008 International Neuromodulation Society.

Entities:  

Year:  2008        PMID: 22151039     DOI: 10.1111/j.1525-1403.2008.00147.x

Source DB:  PubMed          Journal:  Neuromodulation        ISSN: 1094-7159


  6 in total

1.  Intrathecal catheter tip inflammatory mass lesions (granulomas): a case report with bone destruction and review of imaging findings.

Authors:  Beril Gok; Mohammadreza Hayeri; Richard Kanoff; Michael Brooks
Journal:  Emerg Radiol       Date:  2012-07-06

Review 2.  Intrathecal therapy for chronic pain: current trends and future needs.

Authors:  Salim M Hayek; Michael C Hanes
Journal:  Curr Pain Headache Rep       Date:  2014-01

3.  Catheter obstruction of intrathecal drug administration system -a case report-.

Authors:  Seok Myeon Rhee; Eun Joo Choi; Pyung Bok Lee; Francis Sahngun Nahm
Journal:  Korean J Pain       Date:  2012-01-02

4.  A Patient with an Intradural Tumor: An Unexpected Finding.

Authors:  Devang Padalia; Allan R Escher; Nasrin N Aldawoodi; Neal Shah
Journal:  Cureus       Date:  2020-03-23

5.  Intrathecal catheter-associated inflammatory mass in a neurofibromatosis type-1 patient receiving fentanyl and bupivacaine.

Authors:  Derek G Southwell; Joseph A Osorio; Christopher S Liverman; Lauren M Friedman; Ramana K Naidu; Lawrence R Poree; Melanie M Henry; Line Jacques
Journal:  Surg Neurol Int       Date:  2017-07-25

6.  Restoration of rostral cerebrospinal fluid flow to solve treatment failure caused by obstruction in long-term intrathecal baclofen administration.

Authors:  Elmar M Delhaas; Biswadjiet S Harhangi; Pieter J van Doormaal; Wouter Dinkelaar; Ad C G M van Es; Danielle M E van Assema; Sander P G Frankema; Aad van der Lugt; Frank J P M Huygen
Journal:  J Spinal Cord Med       Date:  2019-08-16       Impact factor: 1.985

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.